BRPI0807612A2 - Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo - Google Patents

Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo

Info

Publication number
BRPI0807612A2
BRPI0807612A2 BRPI0807612-0A BRPI0807612A BRPI0807612A2 BR PI0807612 A2 BRPI0807612 A2 BR PI0807612A2 BR PI0807612 A BRPI0807612 A BR PI0807612A BR PI0807612 A2 BRPI0807612 A2 BR PI0807612A2
Authority
BR
Brazil
Prior art keywords
methods
diabetic conditions
metabolic markers
metabolic
markers
Prior art date
Application number
BRPI0807612-0A
Other languages
English (en)
Inventor
Steven M Watkins
Michelle M Wiest
Original Assignee
Tethys Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tethys Bioscience Inc filed Critical Tethys Bioscience Inc
Publication of BRPI0807612A2 publication Critical patent/BRPI0807612A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
BRPI0807612-0A 2007-02-22 2008-02-22 Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo BRPI0807612A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90297607P 2007-02-22 2007-02-22
US93176607P 2007-05-24 2007-05-24
US2185308P 2008-01-17 2008-01-17
PCT/US2008/002357 WO2008106054A2 (en) 2007-02-22 2008-02-22 Metabolic markers of diabetic conditions and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0807612A2 true BRPI0807612A2 (pt) 2015-06-16

Family

ID=39721790

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807612-0A BRPI0807612A2 (pt) 2007-02-22 2008-02-22 Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo

Country Status (8)

Country Link
US (1) US20100197028A1 (pt)
EP (1) EP2126589A4 (pt)
JP (1) JP2010519543A (pt)
CN (1) CN101802620A (pt)
AU (1) AU2008219700B2 (pt)
BR (1) BRPI0807612A2 (pt)
CA (1) CA2678670A1 (pt)
WO (1) WO2008106054A2 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007133586A2 (en) * 2006-05-08 2007-11-22 Tethys Bioscience, Inc. Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
EP2313773A1 (en) * 2008-07-15 2011-04-27 Metanomics Health GmbH Means and methods diagnosing gastric bypass and conditions related thereto
US20120122981A1 (en) * 2009-03-31 2012-05-17 Yun Fu Hu Biomarkers Related to Insulin Resistance and Methods using the Same
JP5746154B2 (ja) * 2009-05-28 2015-07-08 ザ クリーブランド クリニック ファウンデーションＴｈｅ Ｃｌｅｖｅｌａｎｄ ＣｌｉｎｉｃＦｏｕｎｄａｔｉｏｎ 疾患の診断および予測のためのトリメチルアミン含有化合物
US11835503B2 (en) * 2009-05-28 2023-12-05 The Cleveland Clinic Foundation TMA-formation inhibitor treatment for elevated TMA-containing compound diseases
US9217747B2 (en) * 2009-10-29 2015-12-22 Health Diagnostic Laboratory, Inc. Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
EP2580596B1 (en) 2010-06-10 2015-02-25 Metanomics Health GmbH Methods to diagnose liver diseases
US10226209B2 (en) 2010-10-15 2019-03-12 Brain Sentinel, Inc. Method and apparatus for classification of seizure type and severity using electromyography
KR101303825B1 (ko) * 2011-06-02 2013-09-05 연세대학교 산학협력단 혈장 대사체를 이용한 제2형 당뇨병 진단 키트
MX358279B (es) * 2011-07-05 2018-08-13 Brain Sentinel Inc Metodo y aparato para detectar convulsiones.
JP6158186B2 (ja) 2011-09-14 2017-07-05 メタボロン，インコーポレイテッド インスリン抵抗性に関連するバイオマーカーおよびそれを使用する方法
CN102495217B (zh) * 2011-12-06 2014-06-25 黄传峰 一种临床病例监测管理系统
CA2903946A1 (en) * 2013-03-08 2014-09-12 Zora Biosciences Oy Non-high density lipoprotein derived cvd markers
AU2014377039A1 (en) * 2014-01-08 2016-05-26 Société des Produits Nestlé S.A. Biomarkers for epicardial adipose tissue
WO2015109116A1 (en) * 2014-01-15 2015-07-23 The Regents Of The University Of California Metabolic screening for gestational diabetes
WO2016049828A1 (zh) * 2014-09-30 2016-04-07 深圳华大基因科技有限公司 肥胖人群特异性生物标志组合物及其用途
US11255866B2 (en) * 2015-02-26 2022-02-22 Wisconsin Alumni Research Foundation Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations
CN105628809B (zh) * 2015-12-25 2018-04-03 中国药科大学 用于诊断区分冠状动脉粥样硬化和冠心病的代谢标志物
CN105486773A (zh) * 2015-12-25 2016-04-13 齐炼文 用于诊断冠心病的代谢标志物
CN105424841B (zh) * 2015-12-25 2017-11-03 齐炼文 用于诊断冠状动脉粥样硬化的代谢标志物
CN106979982B (zh) * 2016-01-19 2021-01-05 上海市第六人民医院 一种用于糖尿病风险预测、治疗评价的方法及试剂盒
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN105486778B (zh) * 2016-01-25 2017-11-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
CN107121540B (zh) * 2016-02-24 2020-06-12 中国科学院上海营养与健康研究所 酰基肉碱谱或其检测试剂在2型糖尿病发病风险预测中的应用
CN106483212B (zh) * 2016-09-22 2019-03-01 南京医科大学 与特发性男性不育相关的尿液雌激素代谢物标志物及其检测方法和应用
CN106680473B (zh) * 2017-01-23 2019-04-09 首都医科大学附属北京朝阳医院 生物标志物在筛选治疗或缓解代谢综合征的药物中的用途
CN108152502A (zh) * 2017-11-23 2018-06-12 上海阿趣生物科技有限公司 可用于检测糖尿病早期的组合标志物及其用途
KR102377089B1 (ko) 2018-11-27 2022-03-21 대한민국 전당뇨 진단 키트 및 진단 방법
CN109709228B (zh) * 2019-01-14 2022-06-14 上海市内分泌代谢病研究所 脂质联合标志物在制备诊断糖尿病的检测试剂或检测物的用途
CN112697889B (zh) * 2019-10-22 2022-03-08 中国科学院大连化学物理研究所 一种血清代谢标志物的用途及检测试剂盒
JP6725928B1 (ja) * 2020-02-13 2020-07-22 東洋インキＳｃホールディングス株式会社 回帰モデル作成方法、回帰モデル作成装置、及び、回帰モデル作成プログラム
CN112268962B (zh) * 2020-09-08 2022-12-23 南京医科大学 长链酰基肉碱作为缺血性脑卒中生物标志物的应用
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用
CN112230003B (zh) * 2020-11-05 2022-06-21 江苏省中医院 三种血清脂质联合用于糖尿病肾病诊断的用途
CN112630330B (zh) * 2020-12-08 2021-12-21 河北医科大学第二医院 小分子物质在脑梗死诊断中的应用
WO2022133738A1 (zh) * 2020-12-22 2022-06-30 中山大学附属第一医院 一种术前鉴别甲状腺良恶性结节的生物标志物、试剂盒及其应用
CN112986425B (zh) * 2021-02-09 2023-07-04 首都医科大学 Pm2.5对脂质代谢影响的检测标志物及应用
CN113008972B (zh) * 2021-02-26 2023-03-24 南芯芯仪(广州)制造有限公司 用于妊娠期糖尿病诊断的血清代谢标志物及其应用
CN115112776B (zh) * 2021-03-18 2023-07-04 中国科学院大连化学物理研究所 联合标志物及在诊断心房颤动中应用及诊断试剂或试剂盒
CN113484511B (zh) * 2021-06-30 2023-07-04 华中科技大学 妊娠期糖尿病的孕早期血液脂质生物标志物的筛选及应用
CN114317671B (zh) * 2021-12-27 2024-04-16 复旦大学附属儿科医院 可作为1型糖尿病生物标志物的肠道细菌和粪便代谢物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE532070T1 (de) * 2000-12-14 2011-11-15 Brigham & Womens Hospital Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
AU2002348574A1 (en) * 2001-09-24 2003-04-07 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
AU2005284830A1 (en) * 2004-09-13 2006-03-23 Lipomics Technologies, Inc. Metabolite markers for weight management
US20070218519A1 (en) * 2005-10-11 2007-09-20 Tethys Bioscience, Inc. Diabetes-associated markers and methods of use thereof

Also Published As

Publication number Publication date
AU2008219700B2 (en) 2014-05-29
JP2010519543A (ja) 2010-06-03
EP2126589A2 (en) 2009-12-02
EP2126589A4 (en) 2011-06-08
WO2008106054A2 (en) 2008-09-04
WO2008106054A3 (en) 2008-12-11
AU2008219700A1 (en) 2008-09-04
CN101802620A (zh) 2010-08-11
CA2678670A1 (en) 2009-09-04
US20100197028A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
BRPI0807612A2 (pt) Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo
SMT201600278B (it) Inibitori della benzossazolo chinasi e metodi d'uso
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
FI20075532A0 (fi) Uusia esteraaseja ja niiden käyttö
BR112012003661A2 (pt) "compostos de biarila e métodos de uso dos mesmos."
BRPI0820457A2 (pt) Fluidos de ruptura e métodos de uso dos mesmos
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI0817879A2 (pt) Composições e métodos de uso de anticorpos contra esclerostina
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
CR20130360A (es) Compuesto heterocíclico y su uso
BRPI1012990A2 (pt) "dispositivo de monitoramento de analito e métodos de uso"
BRPI0906186A2 (pt) composto e uso de um composto
BRPI0915959A2 (pt) silanos de éter fluorados e métodos de uso dos mesmos
BRPI0908268A2 (pt) compostos do inibidor de raf e seus métodos de uso
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0814330A2 (pt) métodos e kits cirúrgicos
BRPI0807495A2 (pt) Adjuvantes e métodos de emrpego dos mesmos
DK2038275T3 (da) Ny pyridazinforbindelse og anvendelse heraf
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI0813355A2 (pt) Compostos de quinazolinona e métodos de uso dos mesmos
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
BRPI0907064A2 (pt) "métodos e sistemas"

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL